Toyoki Mori

Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V₂ receptor antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Hiroshi Yamashita et al. · British Journal of Pharmacology · 1992 · 347 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats

Yoshitaka Yamamura, Shigeki Nakamura, S. Itoh et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 332 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +12

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Tomihiko Chihara et al. · Science · 1991 · 272 citations

Medicine, Pharmacology, Physiology +17

The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions

Akito Tanoue, Shuji Ito, Kenji Honda et al. · Journal of Clinical Investigation · 2004 · 222 citations · Full text

Life Sciences, Endocrinology, Physiology +17

The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions

Akito Tanoue, Shuji Ito, Kenji Honda et al. · Journal of Clinical Investigation · 2004 · 212 citations · Full text

Life Sciences, Endocrinology, Physiology +17